PSA Screening Shows Sustained Prostate Cancer Mortality Reduction in 23-Year Study
Research demonstrates 13% relative reduction in prostate cancer deaths but highlights overdiagnosis concerns, prompting calls for risk-based screening approaches.
Research demonstrates 13% relative reduction in prostate cancer deaths but highlights overdiagnosis concerns, prompting calls for risk-based screening approaches.
Teams complete whole human genome sequencing and analysis in under four hours, demonstrating potential for same-day NICU workflows.
New recommendations address testing challenges when direct oral anticoagulants interfere with coagulation assays.
The collaboration combines liquid handling technology with ultra-sensitive transcriptomic workflows to improve throughput and reproducibility.
The test measures microRNA-371a-3P biomarker and can guide treatment decisions while reducing need for some CT scans during surveillance.